Belite Bio, Inc
NASDAQ:BLTE
62 (USD) • At close December 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Assets: | ||||
| Current Assets: | ||||
| Cash & Cash Equivalents
| 88.157 | 42.089 | 17.344 | 25.618 |
| Short Term Investments
| 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 88.157 | 42.089 | 17.344 | 25.618 |
| Net Receivables
| 0.867 | 0.019 | 0.023 | 0.04 |
| Inventory
| 0 | -0.019 | 0 | 0 |
| Other Current Assets
| 0.916 | 0.699 | 0.064 | 0.01 |
| Total Current Assets
| 89.94 | 42.807 | 17.431 | 25.668 |
| Non-Current Assets: | ||||
| Property, Plant & Equipment, Net
| 1.301 | 1.378 | 0.094 | 0.066 |
| Goodwill
| 0 | 0 | 0 | 0 |
| Intangible Assets
| 3.235 | 0.031 | 0 | 0 |
| Goodwill and Intangible Assets
| 3.235 | 0.031 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.166 | 0.057 | 0.823 | 0.007 |
| Total Non-Current Assets
| 4.702 | 1.466 | 0.917 | 0.073 |
| Total Assets
| 94.642 | 44.273 | 18.348 | 25.741 |
| Liabilities & Equity: | ||||
| Current Liabilities: | ||||
| Account Payables
| 0 | 0 | 0 | 0 |
| Short Term Debt
| 0.308 | 0.396 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 3.325 | 1.708 | 1.635 | 0.972 |
| Total Current Liabilities
| 3.633 | 2.104 | 1.635 | 0.972 |
| Non-Current Liabilities: | ||||
| Long Term Debt
| 0.578 | 0.668 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 0.578 | 0.668 | 31.806 | 31.806 |
| Total Liabilities
| 4.211 | 2.772 | 33.441 | 32.778 |
| Equity: | ||||
| Preferred Stock
| 0 | 0 | 0.032 | 0.032 |
| Common Stock
| 0.003 | 0.003 | 0.001 | 0.001 |
| Retained Earnings
| -71.503 | -39.871 | -27.223 | -17.557 |
| Accumulated Other Comprehensive Income/Loss
| -0.374 | -0.392 | -0.196 | -0.044 |
| Other Total Stockholders Equity
| 162.305 | 81.761 | 12.325 | 10.563 |
| Total Shareholders Equity
| 90.431 | 41.501 | -15.093 | -7.037 |
| Total Equity
| 90.431 | 41.501 | -15.093 | -7.037 |
| Total Liabilities & Shareholders Equity
| 94.642 | 44.273 | 18.348 | 25.741 |